Dr. Peter W. Mullen was a tenured faculty member of the Department of Pharmacology at the University of Manchester Medical School prior to establishing Kemic Bioresearch. His research interests in pharmacokinetics and toxicology include: 'pk' modeling and simulation, forensic toxicokinetics, bioavailability and the effects of immune modulation on drug disposition. Dr. Mullen is a former editor of the International Journal of Immunopharmacology and a current member of the editorial board of the International Journal of Clinical Pharmacology and Therapeutics. A member of many learned societies including the AACT, BPS, CSPT, CSFS, ISES, SOTC and TIAFT, he also serves on the board of the Nova Scotia Health Research Foundation.  He has organized several scientific conferences including a NATO Advanced Study Institute and the 1998 Annual Meeting of the Canadian Society of Forensic Science. Kemic's acclaimed basic pharmacokinetics course has been presented by Dr. Mullen at various venues internationally.

Dr. John R. Carpenter holds degrees in pharmacology from both British (B.Sc, London) and Canadian (Ph.D., Alberta) universities. Currently a freelance medical communications consultant and medical writer, Dr. Carpenter also taught medical, pharmacy and science students at the University of Manchester for 18 years.  In addition to original publications in the scientific literature, Dr. Carpenter has contributed to several texts including Basic Pharmacology (ed. R.W. Foster).  He is also the author of Pharmacology from A to Z and co-author (with Prof. D. Laurence) of A Dictionary of Pharmacology and Allied Topics.

Dr. David W. A. Bourne is Professor of Pharmaceutics in the College of Pharmacy, University of Oklahoma.  Internationally recognized for his work concerning the mathematical modeling of pharmacokinetic data and the development of related software, Dr. Bourne has also been a consultant in pharmacokinetics to the UN Industrial Development Organization and the pharmaceutical industry.  He has held academic appointments in both Australia and the United States.  He is a member of AAPS and ASCPT  and  currently serves on the Editorial Advisory Board of the Journal of Pharmaceutical Sciences.

Dr. Arthur B. Straughn  is Professor and Director of the Drug Research Laboratory, College of Pharmacy, University of Tennessee, Memphis where he has received several excellence in teaching awards.  Dr. Straughn's teaching, research and over 60 publications are in the areas of bioavailability, pharmacokinetics and assay methodology.  Since 1974 as principal or co- investigator, Dr. Straughn has attracted extramural funding in excess of $10 million  in support of his research from such sources as the National Cancer Institute, the FDA, the Tennessee Dept. of Public Health and Environment and the pharmaceutical industry.